Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

nufacturing and analytical strategy for guaranteeing the consistency of its drug products. The Company is currently concluding work on the analytical method application and the commercial scale manufacturing batches.
  • Bionovo presented the positive results of its Phase 2 clinical trial of Menerba to the international women's health community at the 8th Annual European Society for Gynecology (EGS) in Rome, Italy. The overall reaction of the European scientific, clinical, and pharmaceutical community was extremely positive and demonstrated an international interest in finding a safer alternative to hormone therapy for the treatment of menopausal vasomotor symptoms.
  • The Company presented the results of a study on the effects of two plant-derived, tissue-selective estrogen receptor alpha (ERa) modulators (TSERaM) on menopausal obesity at the 20th Annual Meeting of the North American Menopause Society. In this study, plant-derived TSERaMs, like estrogens, were shown to reduce body fat in mice, but while estrogens also caused cell proliferation in the mammary gland and uterus, the plant-derived TSERaMs did not elicit these potentially cancer-causing side effects. These results suggest that the development of botanically-derived, tissue-selective ERa modulators could result in a safer alternative for the treatment of menopausal weight gain, a condition that can lead to the development of metabolic syndrome, a combination of risk factors for cardiovascular disease and diabetes.
  • Bionovo published a paper describing the molecular mechanisms underlying the selective cytotoxic activity of its preclinical drug candidate BN108 and its active compound, timosaponin AIII (TAIII), in the peer-reviewed, open-access journal, Public Library of Science One. BN108 and TAIII kill tumor cells by eliciting two responses: first, they inhibit mTORC1, an oncogenic pathway that is abnormally activated in many tumors, and second, they induce a profound stress in the en
    '/>"/>

  • SOURCE Bionovo, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
    2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
    3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
    4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
    5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
    6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
    9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
    10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
    11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)...  Actavis plc (NYSE: ACT ) ... complete response letter from the U.S. Food and ... (NDA) for the fixed-dose combination (FDC) of nebivolol ... Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... of a complete response letter, Actavis remains committed ...
    (Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
    (Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
    Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
    ... Mindray Medical International Limited (NYSE: MR ), ... worldwide, today announced shareholder resolutions adopted at its annual ... December 22, 2010. At the meeting, Mindray ... I-Yin Hsu and Mr. Wu Qiyao, each to serve ...
    ... Dec. 27, 2010 Cephalon, Inc. (Nasdaq: ... second Complete Response Letter from the U.S. Food and ... (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV] for the treatment ... disorder resulting from eastbound travel.  In its letter to ...
    Cached Medicine Technology:Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 2Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 3
    (Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
    (Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
    (Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
    (Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
    (Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... esthetician, Karen,Dunlap, has developed an advanced anti-aging procedure ... most nutritious and powerful food,in the world -- ... and,nature, Dunlap discovered that topical application of the ... Her new signature facial, the,Acai Berry Anti-Aging Facial, ...
    ... 4 Trust for America,s,Health warns that the proposed ... and Prevention (CDC) in the president,s fiscal year 2009,budget ... the budget,for CDC would fall to a six year ... healthcare costs are skyrocketing, we should be,investing more to ...
    ... February 4, 2008 The U.S. Pharmacopeia (USP) ... Spanish edition of its core compendia, the United ... available for purchase. The official edition for 2008, ... more than 4,000 quality pharmaceuticals, excipients, dietary supplements, ...
    ... N.J., Feb. 4 Milestone Scientific,Inc. (OTC Bulletin ... today announced that Scott Mahnken has joined the,Company,s ... with,developing and managing a wide range of strategic ... brand awareness,and drive sales growth, Mahnken will report ...
    ... AUDUBON, Pa., Feb. 4 Globus Medical, Inc., the ... announced,record revenue for the year ending December 31, 2007. ... of 50 percent over the $82 million,it achieved in ... significant milestones achieved,by the Company during 2007. "This has ...
    ... on The Burden of Rheumatoid Arthritis and Patient Access ... Economics (Sweden), the University of Lund (Sweden) and the ... highest cost in rheumatoid arthritis results from patients having ... The study has just been published online in ...
    Cached Medicine News:Health News:Breakthrough 'Acai Berry Anti-Aging Facial' Applies Benefits of Nature's Super-Food to the Skin 2Health News:Cuts to HHS Could Leave Americans' Health in Critical Condition, TFAH Says; New Poll Shows Americans Believe Disease Prevention is Key to Reducing Healthcare Costs 2Health News:USP publishes Spanish edition of United States Pharmacopeia and National Formulary 2Health News:Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing 2Health News:Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing 3Health News:Globus Medical Announces Record Revenue for 2007 2Health News:Rheumatoid arthritis sends many into early retirement 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    CUSA DISSECTRON PORTABLE UNIT is an ultrasonic surgical aspirator for the fragmentation and emulsification of tissue available only outside the United States....
    ... The Surgical Foam Headrest automatically secures ... patient as comfortable as possible. Several ... adjust for any head size from ... be autoclaved when necessary. From surgical ...
    ... These focusing prismatic telescope are available in ... and 4.2x can be spectacle mounted or supplied ... The 8.25x is a hand held telescope. ,Small ... ideal for reading signposts, bus numbers, etc. ...
    Medicine Products: